FIGURE 1.

The mortality and morbidity of GVHD decreased in BMT by berberine (N = 10/group). (A) Changes in body weight every 4 days. (B) Percentage of survival. (C) Mean clinical scores every 4 days. (D) The flow chart of the following experimental procedures. Data are shown as mean ± SD and were analysed by Multiple t tests. *p < 0.05 and **p < 0.01 between model and berberine groups at the indicated time points. The graph (A and C) show the data combined with three independent experiments (10–15 animals in each group)